Accéder directement au contenu Accéder directement à la navigation
Article dans une revue

Validation of a Score for the Detection of Subjects with High Risk for Severe High-Altitude Illness

Jean-Paul Richalet 1, 2 Fabien Pillard 3, 4 David Le Moa 2 Daniel Rivière 3, 4 Philippe Oriol 5 Mathias Poussel 6 Bruno Chenuel 6 Stephane Doutreleau 7, 8 Samuel Verges 7, 8 Sophie Demanez 9 Michel Vergnion 9 Jean-Michel Boulet 10 Herve Douard 10 Maryse Dupré 11 Olivier Mesland 11 Romain Remetter 12 Evelyne Lonsdorfer-Wolf 12 Alain Frey 13 Louis Vilcoq 13 Anne Nedelec-Jaffuel 13 David Debeaumont 14 Guy Duperrex 15 François Lecoq 15 Christophe Hédon 16, 17 Maurice Hayot 16, 17 Guido Giardini 18 François J. Lhuissier 2, 19
Abstract : Purpose: A decision tree based on a clinico-physiological score (SHAI score) has been developed to detect subjects susceptible to Severe High Altitude Illness (SHAI). We aimed to validate this decision tree, to rationalize the prescription of acetazolamide (ACZ) and to specify the rule for a progressive acclimatization.Methods: Data were obtained from 641 subjects in 15 European medical centers before and during a sojourn at high altitude. Depending on the value of SHAI score, advice was given and ACZ was eventually prescribed. The outcome was the occurrence of SHAI at high altitude as a function of SHAI score, ACZ prescription and use and fulfillment of the acclimatization rule.Results: The occurrence of SHAI was 22.6%, similar to what was observed 18 years before (23.7%), while life-threatening forms of SHAI (High Altitude Pulmonary and Cerebral Edema) were less frequent (2.6% to 0.8%, P=0.007). The negative predictive value of the decision tree based was 81%, suggesting that the procedure is efficient to detect subjects who will not suffer from SHAI, therefore limiting the use of ACZ. The maximal daily altitude gain that limits the occurrence of SHAI was established at 400 m. The occurrence of SHAI was reduced from 27% to 12% when the recommendations for ACZ use and 400 m daily altitude gain were respected (P<0.001).Conclusion: This multicenter study confirmed the interest of the SHAI score in predicting the individual risk for SHAI. The conditions for an optimized acclimatization (400 m-rule) were also specified and we proposed a rational decision tree for the prescription of acetazolamide, adapted to each individual tolerance to hypoxia
Type de document :
Article dans une revue
Liste complète des métadonnées

https://hal.archives-ouvertes.fr/hal-03108569
Contributeur : Dominique Mornet Connectez-vous pour contacter le contributeur
Soumis le : lundi 15 novembre 2021 - 13:25:17
Dernière modification le : jeudi 25 novembre 2021 - 09:28:02

Fichier

2021 RICHALET et al., validati...
Fichiers produits par l'(les) auteur(s)

Licence


Distributed under a Creative Commons Paternité - Pas d'utilisation commerciale 4.0 International License

Identifiants

Citation

Jean-Paul Richalet, Fabien Pillard, David Le Moa, Daniel Rivière, Philippe Oriol, et al.. Validation of a Score for the Detection of Subjects with High Risk for Severe High-Altitude Illness. Medicine and Science in Sports and Exercise, American College of Sports Medicine (ACSM), 2021, 53 (6), pp.1294-1302. ⟨10.1249/MSS.0000000000002586⟩. ⟨hal-03108569⟩

Partager

Métriques

Consultations de la notice

122

Téléchargements de fichiers

21